**EMERGENCY DEPARTMENT CLINICAL ENCOUNTER NOTE — DRAFT** *This is a documentation draft only. All clinical decisions, diagnoses, medication orders, and treatment plans must be reviewed and finalized by the treating clinician prior to use.* --- # SECTION 1: CLINICAL ENCOUNTER SUMMARY ## Chief Complaint Acute substernal chest pain. ## History of Present Illness (HPI) — OLDCARTS Framework **Onset:** Chest pain began approximately 2 hours prior to ED arrival while the patient was mowing the lawn. **Location:** Substernal chest region. **Duration:** Persistent since onset; ongoing at time of evaluation. **Character:** Patient describes the pain as “crushing.” **Aggravating Factors:** Occurred during exertion (mowing lawn). No specific positional or respiratory aggravating factors documented. **Relieving Factors:** No relief with rest. No documentation of response to medications prior to arrival. **Timing:** Acute onset, continuous for approximately 2 hours prior to presentation. **Severity:** 8/10 in intensity. **Radiation:** Radiates to the left arm and jaw. **Associated Symptoms:** * Diaphoresis * Nausea * Shortness of breath * Anxiety **Pertinent Negatives (as documented):** * No known drug allergies * No documented prior cardiac catheterization * No pulmonary edema on imaging * No peripheral edema * JVP not elevated **Pre-Hospital Course:** Arrived via ambulance. On arrival, patient appeared anxious and diaphoretic. --- # SECTION 2: SYSTEMATIC REVIEW AND EXAMINATION FINDINGS ## A) Vital Signs Assessment * **Blood Pressure:** 168/98 mmHg (elevated; hypertensive range) * **Heart Rate:** 102 bpm (tachycardic) * **Respiratory Rate:** 22 breaths/min (mildly elevated) * **SpO₂:** 94% on room air (borderline low-normal) * **Temperature:** 37.1°C (afebrile) No trending vital data provided. Clinician may wish to document repeat vitals and response to treatment. --- ## B) System-by-System Physical Examination **General Appearance:** Alert male, anxious and diaphoretic. **Cardiovascular:** Tachycardic. S4 gallop present. No peripheral edema. JVP not elevated. **Respiratory:** Lungs clear to auscultation bilaterally. No evidence of pulmonary edema. **Extremities:** No peripheral edema documented. **Other Systems:** Additional examination findings (HEENT, abdominal, neurologic, vascular exam including pulse symmetry) not provided and may be documented if performed. --- ## C) Diagnostic Study Results ### Electrocardiogram (ECG) * ST-elevation in leads II, III, and aVF * Reciprocal ST-depression in leads I and aVL Consistent with inferior wall ST-elevation myocardial infarction (STEMI). ### Cardiac Biomarkers * **Troponin I:** 2.4 ng/mL (elevated; reference <0.04 ng/mL) ### Complete Blood Count (CBC) * Within normal limits (specific values not provided) ### Basic Metabolic Panel (BMP) * **Glucose:** 186 mg/dL (elevated) * **Creatinine:** 1.1 mg/dL (within normal range) ### Chest X-Ray * Mild cardiomegaly * No pulmonary edema ### Pending Studies Not specified. Clinician may wish to document if repeat troponin levels, coagulation studies, or additional imaging were ordered. --- ## D) Clinical Severity Notation Presentation consistent with acute coronary syndrome with diagnostic ECG changes meeting STEMI criteria. High-risk features include: * Ongoing chest pain * ST-segment elevation * Elevated troponin * Multiple cardiovascular risk factors No formal risk score documented (e.g., TIMI, GRACE). Clinician may add if utilized. --- # SECTION 3: DIFFERENTIAL DIAGNOSIS DOCUMENTATION ## A) Primary Working Diagnosis **Acute ST-Elevation Myocardial Infarction (STEMI), Inferior Wall** ### Supporting Clinical Findings: * Acute substernal crushing chest pain with radiation to left arm and jaw * Associated diaphoresis, nausea, dyspnea * ST-elevation in II, III, aVF with reciprocal changes * Elevated Troponin I (2.4 ng/mL) * Cardiovascular risk factors (HTN, DM2, hyperlipidemia, smoking history, family history) Clinician impression: High diagnostic certainty for acute inferior STEMI. --- ## B) Additional Diagnostic Considerations ### 1. Aortic Dissection **Supporting Features (considered):** * Acute chest pain **Contradicting Evidence:** * ECG diagnostic for STEMI * No documented pulse deficits * No mediastinal widening reported on CXR * Pain described as crushing rather than tearing ### 2. Pulmonary Embolism **Supporting Features (considered):** * Dyspnea * Tachycardia **Contradicting Evidence:** * Clear diagnostic ST-elevation pattern * No hypoxia beyond mild reduction (SpO₂ 94%) * No evidence of right heart strain documented ### 3. Tension Pneumothorax **Contradicting Evidence:** * Clear lungs on auscultation * No unilateral breath sound absence * No tracheal deviation * CXR without pneumothorax --- ## C) Diagnoses to Exclude * Aortic dissection * Pulmonary embolism * Tension pneumothorax These were considered but deemed less likely based on ECG findings and overall presentation. Emergent PCI prioritized due to time-sensitive STEMI diagnosis. --- ## D) Clinical Reasoning Narrative The patient presents with classic anginal symptoms and ECG findings diagnostic for inferior STEMI. The presence of reciprocal ST changes strengthens diagnostic specificity. Elevated troponin confirms myocardial injury. Given time-sensitive myocardial salvage considerations, emergent percutaneous coronary intervention (PCI) is indicated. Alternative life-threatening diagnoses were considered but are less consistent with current findings. --- # SECTION 4: TREATMENT AND MANAGEMENT PLAN DOCUMENTATION ## A) Immediate Interventions **Plan:** Emergent percutaneous coronary intervention (PCI). Medication orders not specified in input. Clinician may document: * Aspirin (dose, route) * P2Y12 inhibitor * Anticoagulation (e.g., heparin) * Nitroglycerin * Morphine (if used) * Oxygen (if indicated) * Beta-blocker (if indicated and not contraindicated) Continuous cardiac monitoring initiated. --- ## B) Ongoing Management Documentation * Activation of cardiac catheterization lab * Cardiology consultation * Serial troponin measurements (if ordered) * Continuous telemetry monitoring * Blood pressure and glycemic management Clinician may document detailed post-PCI plan once completed. --- ## C) Patient Education Documentation Patient informed of: * Diagnosis of acute myocardial infarction * Need for emergent PCI * Risks and benefits of procedure Lifestyle factors to address: * Smoking cessation reinforcement * Medication adherence * Weight management * Glycemic and blood pressure control Shared decision-making discussion to be documented in further detail by clinician. --- ## D) Safety Netting Documentation As this is an emergent admission for PCI, standard return precautions are superseded by inpatient management. Post-discharge warning signs should include: * Recurrent chest pain * Shortness of breath * Syncope * Bleeding (if on anticoagulation) --- # SECTION 5: FOLLOW-UP AND CONTINUITY PROTOCOL ## A) Short-Term (24–72 Hours) * Post-PCI monitoring * Hemodynamic stabilization * Serial cardiac biomarkers * Echocardiogram (if ordered) ## B) Medium-Term (1–4 Weeks) * Cardiology follow-up * Medication optimization * Lipid panel reassessment * Diabetes and BP control reassessment ## C) Long-Term (1–6 Months) * Cardiac rehabilitation referral * Secondary prevention strategies * Ongoing risk factor modification ## D) Care Coordination Notes * Communication with cardiology * Transition planning to inpatient cardiology service * PCP notification recommended --- # SECTION 6: CODING REFERENCE SECTION **FOR CLINICIAN/CODER VERIFICATION** ## A) ICD-10 Code Suggestions * I21.19 — ST elevation (STEMI) myocardial infarction involving other coronary artery of inferior wall * I10 — Essential (primary) hypertension * E11.9 — Type 2 diabetes mellitus without complications * E78.5 — Hyperlipidemia, unspecified * Z87.891 — Personal history of nicotine dependence ## B) E&M Level Reference (FOR VERIFICATION) Likely high-complexity medical decision-making due to: * Life-threatening condition * Interpretation of ECG * Elevated troponin * Emergent intervention * Multiple comorbidities ## C) Medical Necessity Documentation Checklist * Emergent PCI justified by STEMI ECG findings * Cardiac biomarkers ordered due to suspected ACS * Continuous cardiac monitoring due to arrhythmia risk * Imaging to exclude alternative diagnoses ## D) Quality Measure Reminders * Door-to-balloon time documentation * Aspirin administration timing * Beta-blocker and statin therapy documentation * Smoking cessation counseling * Referral to cardiac rehabilitation --- # SECTION 7: DOCUMENTATION COMPLETENESS CHECKLIST ## A) Documentation Reminders * Time of symptom onset (precise clock time) * Time of ECG acquisition * Time of cath lab activation * Medications administered with dose/route/time * Informed consent documentation * Code status ## B) Medication Safety Reminders * Verify renal dosing (creatinine 1.1 mg/dL) * Review metformin continuation/holding if contrast used * Confirm no drug allergies * Assess for ACE inhibitor continuation ## C) Guideline Reference Notes Commonly applicable: * ACC/AHA STEMI management guidelines * Secondary prevention guidelines * ADA standards for diabetes care ## D) Social Determinants Reminder * Sedentary lifestyle * Prior smoking history * Medication non-compliance Clinician may wish to document financial barriers, access to medications, and social support. --- **END OF DRAFT DOCUMENT** *This document must be reviewed, edited, and approved by the treating clinician prior to inclusion in the medical record.*